Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain receptors in the lungs might help treat a specific type of asthma.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Paroxetine relieves pain by increasing allopregnanolone levels.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The peach gene pCTG134 helps control the interaction between auxin and ethylene hormones during fruit ripening.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

AH-001 could be a safer and more effective treatment for hair loss.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The compounds tested could potentially treat hair loss and alopecia.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Two new compounds were found to effectively reduce hair growth in mice.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.